Bio-Techne (TECH) Revenue & Revenue Breakdown
Bio-Techne Revenue Highlights
Latest Revenue (Y)
$1.16B
Latest Revenue (Q)
$303.43M
Main Segment (Y)
Consumables
Main Geography (Y)
U S
Bio-Techne Revenue by Period
Bio-Techne Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $1.16B | 1.97% |
| 2023-06-30 | $1.14B | 2.81% |
| 2022-06-30 | $1.11B | 18.75% |
| 2021-06-30 | $931.03M | 26.04% |
| 2020-06-30 | $738.69M | 3.46% |
| 2019-06-30 | $714.01M | 11.04% |
| 2018-06-30 | $642.99M | 14.21% |
| 2017-06-30 | $563.00M | 12.82% |
| 2016-06-30 | $499.02M | 10.34% |
| 2015-06-30 | $452.25M | 26.41% |
| 2014-06-30 | $357.76M | 15.19% |
| 2013-06-30 | $310.57M | -1.27% |
| 2012-06-30 | $314.56M | 8.48% |
| 2011-06-30 | $289.96M | 7.77% |
| 2010-06-30 | $269.05M | 1.93% |
| 2009-06-30 | $263.96M | 2.54% |
| 2008-06-30 | $257.42M | 15.19% |
| 2007-06-30 | $223.48M | 10.30% |
| 2006-06-30 | $202.62M | 13.41% |
| 2005-06-30 | $178.65M | 10.79% |
| 2004-06-30 | $161.26M | 11.20% |
| 2003-06-30 | $145.01M | 10.78% |
| 2002-06-30 | $130.90M | 13.47% |
| 2001-06-30 | $115.36M | 11.09% |
| 2000-06-30 | $103.84M | 14.23% |
| 1999-06-30 | $90.90M | 35.07% |
| 1998-06-30 | $67.30M | 10.51% |
| 1997-06-30 | $60.90M | 11.54% |
| 1996-06-30 | $54.60M | 14.47% |
| 1995-06-30 | $47.70M | 18.36% |
| 1994-06-30 | $40.30M | 40.42% |
| 1993-06-30 | $28.70M | - |
Bio-Techne generated $1.16B in revenue during NA 2024, up 1.97% compared to the previous quarter, and up 162.33% compared to the same period a year ago.
Bio-Techne Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $303.43M | 11.31% |
| 2023-12-31 | $272.60M | -1.57% |
| 2023-09-30 | $276.94M | -8.09% |
| 2023-06-30 | $301.32M | 2.44% |
| 2023-03-31 | $294.15M | 8.31% |
| 2022-12-31 | $271.58M | 0.71% |
| 2022-09-30 | $269.65M | -6.44% |
| 2022-06-30 | $288.23M | -0.74% |
| 2022-03-31 | $290.38M | 7.84% |
| 2021-12-31 | $269.28M | 4.48% |
| 2021-09-30 | $257.72M | -0.51% |
| 2021-06-30 | $259.03M | 6.35% |
| 2021-03-31 | $243.55M | 8.61% |
| 2020-12-31 | $224.25M | 9.82% |
| 2020-09-30 | $204.20M | 16.13% |
| 2020-06-30 | $175.83M | -9.68% |
| 2020-03-31 | $194.68M | 5.27% |
| 2019-12-31 | $184.93M | 0.92% |
| 2019-09-30 | $183.24M | -4.39% |
| 2019-06-30 | $191.66M | 3.68% |
| 2019-03-31 | $184.86M | 5.93% |
| 2018-12-31 | $174.51M | 7.08% |
| 2018-09-30 | $162.97M | -9.59% |
| 2018-06-30 | $180.25M | 9.93% |
| 2018-03-31 | $163.97M | 6.37% |
| 2017-12-31 | $154.15M | 6.60% |
| 2017-09-30 | $144.61M | -7.64% |
| 2017-06-30 | $156.58M | 8.71% |
| 2017-03-31 | $144.04M | 9.28% |
| 2016-12-31 | $131.81M | 0.94% |
| 2016-09-30 | $130.58M | -3.10% |
| 2016-06-30 | $134.76M | 2.89% |
| 2016-03-31 | $130.97M | 8.33% |
| 2015-12-31 | $120.91M | 7.59% |
| 2015-09-30 | $112.38M | -4.49% |
| 2015-06-30 | $117.66M | 3.07% |
| 2015-03-31 | $114.16M | 1.97% |
| 2014-12-31 | $111.95M | 3.20% |
| 2014-09-30 | $108.48M | 17.24% |
| 2014-06-30 | $92.52M | -3.17% |
| 2014-03-31 | $95.56M | 13.73% |
| 2013-12-31 | $84.02M | -1.93% |
| 2013-09-30 | $85.67M | 7.79% |
| 2013-06-30 | $79.47M | -1.87% |
| 2013-03-31 | $80.99M | 7.87% |
| 2012-12-31 | $75.08M | 0.08% |
| 2012-09-30 | $75.03M | -4.65% |
| 2012-06-30 | $78.68M | -5.91% |
| 2012-03-31 | $83.62M | 12.00% |
| 2011-12-31 | $74.66M | -3.78% |
| 2011-09-30 | $77.60M | -0.57% |
| 2011-06-30 | $78.04M | 2.32% |
| 2011-03-31 | $76.27M | 12.65% |
| 2010-12-31 | $67.71M | -0.35% |
| 2010-09-30 | $67.94M | 1.85% |
| 2010-06-30 | $66.71M | -5.07% |
| 2010-03-31 | $70.28M | 7.26% |
| 2009-12-31 | $65.52M | -1.52% |
| 2009-09-30 | $66.53M | 2.53% |
| 2009-06-30 | $64.89M | -4.39% |
| 2009-03-31 | $67.87M | 9.68% |
| 2008-12-31 | $61.88M | -10.74% |
| 2008-09-30 | $69.32M | 2.29% |
| 2008-06-30 | $67.77M | -2.52% |
| 2008-03-31 | $69.52M | - |
Bio-Techne generated $303.43M in revenue during Q3 2024, up 11.31% compared to the previous quarter, and up 111.73% compared to the same period a year ago.
Bio-Techne Revenue Breakdown
Bio-Techne Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Jun 24 | Jun 23 |
|---|---|---|
| Instruments | $108.27M | $112.08M |
| Royalty | $23.34M | $21.10M |
| Consumables | $928.18M | $917.73M |
Bio-Techne's latest annual revenue breakdown by segment (product or service), as of Jun 24: Consumables (87.58%), Instruments (10.22%), and Royalty (2.20%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 |
|---|---|---|---|
| Instruments | $27.09M | $26.49M | $29.82M |
| Consumables | $245.78M | $246.73M | $211.13M |
| Royalty | $5.05M | $4.70M | $7.52M |
| Product and Services | - | $298.73M | $265.08M |
| Service | - | $25.50M | $24.13M |
Bio-Techne's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Consumables (88.43%), Instruments (9.75%), and Royalty (1.82%).
Bio-Techne Revenue Breakdown by Country
Annual Revenue by Country
| Country | Jun 24 | Jun 23 |
|---|---|---|
| APAC, excluding Greater China | $73.90M | $73.19M |
| U S | $657.75M | $642.47M |
| United Kingdom | $50.01M | $49.46M |
| Rest Of World | $36.50M | $37.49M |
| C N | $99.47M | $113.87M |
| Europe | $241.43M | $220.23M |
Bio-Techne's latest annual revenue breakdown by geography, as of Jun 24: U S (56.75%), Europe (20.83%), C N (8.58%), APAC, excluding Greater China (6.38%), United Kingdom (4.31%), and Rest Of World (3.15%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 |
|---|---|---|---|
| U S | $177.53M | $173.31M | - |
| APAC, excluding Greater China | $19.26M | $18.25M | $19.04M |
| United Kingdom | $11.77M | $15.12M | - |
| Rest Of World | $10.05M | $10.61M | - |
| C N | $23.93M | $25.60M | - |
| Europe | $63.56M | $60.53M | - |
| EMEA, excluding United Kingdom | - | $60.53M | $62.54M |
| Greater China | - | $25.60M | $24.46M |
| Rest of World | - | $10.61M | $8.09M |
| United States | - | $173.31M | $147.79M |
Bio-Techne's latest quarterly revenue breakdown by geography, as of Jun 24: U S (58.00%), Europe (20.77%), C N (7.82%), APAC, excluding Greater China (6.29%), United Kingdom (3.84%), and Rest Of World (3.28%).
Bio-Techne Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BGNE | BeiGene | $2.46B | $929.17M |
| BMRN | BioMarin Pharmaceutical | $2.42B | $733.87B |
| UTHR | United Therapeutics | $2.33B | $748.90M |
| EXEL | Exelixis | $1.83B | $478.06M |
| ALNY | Alnylam Pharmaceuticals | $1.83B | $420.15M |
| TECH | Bio-Techne | $1.16B | $303.43M |
| HALO | Halozyme Therapeutics | $829.25M | $290.08M |
| APLS | Apellis Pharmaceuticals | $366.28M | $179.14M |
| LEGN | Legend Biotech | $285.14M | $93.99M |
| ASND | Ascendis Pharma | $266.72M | $95.89M |
| BPMC | Blueprint Medicines | $249.38M | $128.18M |
| TVTX | Travere Therapeutics | $145.24M | $62.90M |
| LQDA | Liquidia | $17.49M | $2.97M |
| PCVX | Vaxcyte | - | - |
| NUVL | Nuvalent | - | - |
| REPL | Replimune Group | - | - |
| VTYX | Ventyx Biosciences | - | - |
| AKRO | Akero Therapeutics | - | - |
TECH Revenue FAQ
What is Bio-Techne’s yearly revenue?
Bio-Techne's yearly revenue for 2024 was $1.16B, representing an increase of 1.97% compared to 2023. The company's yearly revenue for 2023 was $1.14B, representing an increase of 2.81% compared to 2022. TECH's yearly revenue for 2022 was $1.11B, representing an increase of 18.75% compared to 2021.
What is Bio-Techne’s quarterly revenue?
Bio-Techne's quarterly revenue for Q3 2024 was $303.43M, a 11.31% increase from the previous quarter (Q2 2024), and a 3.16% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $272.6M, a -1.57% decrease from the previous quarter (Q1 2024), and a 0.37% increase year-over-year (Q2 2023). TECH's quarterly revenue for Q1 2024 was $276.94M, a -8.09% decrease from the previous quarter (Q4 2023), and a 2.70% increase year-over-year (Q1 2023).
What is Bio-Techne’s revenue growth rate?
Bio-Techne's revenue growth rate for the last 3 years (2022-2024) was 4.84%, and for the last 5 years (2020-2024) was 56.91%.
What are Bio-Techne’s revenue streams?
Bio-Techne's revenue streams in n 24 are Instruments, Royalty, and Consumables. Instruments generated $108.27M in revenue, accounting 10.22% of the company's total revenue, down -3.40% year-over-year. Royalty generated $23.34M in revenue, accounting 2.20% of the company's total revenue, up 10.64% year-over-year. Consumables generated $928.18M in revenue, accounting 87.58% of the company's total revenue, up 1.14% year-over-year.
What is Bio-Techne’s main source of revenue?
For the fiscal year ending Jun 24, the largest source of revenue of Bio-Techne was Consumables. This segment made a revenue of $928.18M, representing 87.58% of the company's total revenue.